3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
12
Neoplasms
7
cyclopia sequence
6
Polycystic Ovary Syndrome
4
Fatigue
4
Obesity
3
Multiple Myeloma
3
Lung Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Prostatic Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pain
2
Neoplasms, Plasma Cell
2
Hematologic Diseases
2
Head and Neck Neoplasms
2
Depression
2
Weight Loss
1
Warts
1
Vomiting
1
Vitamin D Deficiency
1
Urinary Bladder Neoplasms
1
Testicular Neoplasms
1
Small Cell Lung Carcinoma
1
Sleepiness
1
Sezary Syndrome
1
Prostatic Intraepithelial Neoplasia
1
Primary Myelofibrosis
1
Precancerous Conditions
1
Peripheral Nervous System Diseases
1
Periampullary Carcinoma Nos
1
Interventions
Metformin
2
drospirenone and ethinyl estradiol combination
1
cinnulin PF
1
Sugars
1
Population Groups
1
Inositol
1
Glucose Tolerance Test
1
Folic Acid
1
Doxycycline
1
Diet
1
Control Groups
1
Contraceptives, Oral
1
Caloric Restriction
1
Absorptiometry, Photon
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Menstruation Disturbances
×
Sugars
×
Clear all
NCT01788215
2016-01-13
MI-PCOS
University of Rochester
Phase 3
Completed
10 enrolled
14 charts